245 FIRST STREET, CAMBRIDGE, MA
Market cap: $411.3M (2/10/2026)
Price: $1.55
.2AMENDED AND RESTATED EXECUTIVE SEVERANCE AGREEMENT
Investor Presentation
Announces Establishment of Rare Kidney Disease Pipeline
Amendment to License Agreement with MEDICE for Vafseo Supply
Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Provides Update on Vafseo for Non-Dialysis Patients
Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Announces 2023 Stock Incentive Plan
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Confidential Treatment Order
Post-Effective Amendment to Registration Statement